{
    "title": "A bill to mandate a study of the effectiveness of a National Drug Strategy and to provide for an accounting of funds devoted to its implementation, and for other purposes.",
    "content": "SECTION 1. FINDINGS.\n\n    The Congress finds that--\n            (1) there is great disagreement concerning the causes of \n        the problem of epidemic drug addiction in the United States and \n        about the most effective way to reduce it;\n            (2) one of the factors which most inhibits an effective \n        response to the problem of epidemic drug addiction in the \n        United States is the lack of accurate information concerning \n        both the problem and the specific effectiveness of each \n        individual element of the Nation's antidrug effort;\n            (3) evaluating the effectiveness of the individual elements \n        of the Federal program to reduce epidemic drug abuse requires \n        accurately establishing cause and effect relationship \n        concerning drug addiction;\n            (4) the United States has promulgated a National Drug \n        Strategy pursuant to the requirements of the 1988 Anti-Drug \n        Abuse Act and will devote many billions of dollars to antidrug \n        programs for many years to come; and\n            (5) it is in the interests of the Nation that these funds \n        be spent as effectively as possible and that a permanent \n        mechanism exist to audit their expenditure.\n\nSEC. 2. PURPOSES.\n\n    The purposes of this Act are to--\n            (1) require a study of the effectiveness of federally \n        funded antidrug programs; and\n            (2) create a permanent auditing mechanism for federally \n        funded antidrug programs.\n\nSEC. 3. STUDY OF ANTI-DRUG PROGRAMS.\n\n    (a) In General.--The Secretary of Health and Human Services \n(referred to in this Act as the ``Secretary'') shall enter into \nappropriate arrangements with the National Academy of Sciences to \nconduct a comprehensive study and investigation of the effectiveness in \nreducing drug addiction of the various components of the Federal \nantidrug program, including--\n            (1) crop eradication;\n            (2) crop substitution;\n            (3) support for foreign law enforcement;\n            (4) interdiction, including a separate analysis of the \n        effectiveness of the military services in the interdiction \n        effort;\n            (5) education;\n            (6) treatment;\n            (7) support for local law enforcement;\n            (8) criminal justice system reforms; and\n            (9) research, including a separate analysis of \n        effectiveness of pharmocological research and research into \n        other types of medical treatments for drug addiction.\n    (b) Methodology.--The study described in subsection (a) shall to \nthe maximum extent possible--\n            (1) study control for the effects of broad societal changes \n        unrelated to specific antidrug initiatives, such as changing \n        demographic patterns;\n            (2) separate the effects of such component of the Federal \n        antidrug program from the effects of other antidrug \n        initiatives;\n            (3) consider the extent to which the expenditure of Federal \n        funds on job training, education, and other health, education, \n        and welfare programs contribute to reducing epidemic drug \n        addiction;\n            (4) study the cost-effectiveness of each component of the \n        Federal antidrug program, as well as the programs described in \n        paragraph (3); and\n            (5) take into account the social and demographic factors \n        which influence rates and forms of epidemic drug addiction and \n        provide, where possible, information on the effectiveness of \n        the various components of the Federal antidrug program on \n        various demographic subgroups within the population.\n    (c) Reporting.--In conducting the study described in subsection \n(a), the National Academy of Sciences shall provide to the Secretary \nand the Congress--\n            (1) not later than 6 months after the date of enactment of \n        this Act a detailed written description of the manner in which \n        the study will be conducted, including a specific set of goals \n        for the study;\n            (2) not later than 18 months after the date of enactment of \n        this Act the preliminary results of the study; and\n            (3) not later than 2 years after the date of enactment of \n        this Act the final results of the study.\n    (d) Update of Study.--The Secretary shall enter into appropriate \narrangements with the National Academy of Sciences to update the \nresults of the study described in subsection (a) every 2 years \nfollowing the initial report.\n    (e) Assistance From Federal Agencies.--Agencies of the Federal \nGovernment shall provide to the National Academy of Sciences such \ninformation as it may reasonably request for the purpose of conducting \nthe study described in subsection (a).\n\nSEC. 4. AUDIT BY THE GOVERNMENT ACCOUNTING OFFICE.\n\n    (a) In General.--The Government Accounting Office shall provide to \nthe Congress on an annual basis an audit report concerning the \nmanagement and expenditures of the component parts of the Federal \nantidrug program.\n    (b) Separate Components.--The report described in (a) shall contain \na separate section on each of the component parts of the Federal \nantidrug program.\n    (c) Access to Records.--In order to carry out the purposes of this \nsection, the Comptroller General shall have such access to records, \nfiles, personnel, and facilities of the Federal agencies involved in \nthe Federal antidrug program, including the military and intelligence \nservices, as the Comptroller General considers necessary."
}